Skip to main content

Advertisement

Table 1 Clinical and epidemiological characteristics of CLD patients with and without DM

From: Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver disease

  Diabetic Non-diabetic P-value
Number 40 148  
Sex    NS
   Female 9 (22.5%) 26 (17.9%)  
   Male 31 (77.5%) 119 (82.1%)  
Age 50.3 ± 11.4 40.2 ± 10.6 0.000
CLD status    0.000
   Inactive carrier 4 (10.0%) 38 (26.2%)  
   Chronic hepatitis 14 (35.0%) 88 (60.7%)  
   Cirrhosis 22 (55.0%) 19 (13.1%)  
CLD etiology    NS
   HBV 24 (60.0%) 85 (58.6%)  
   HCV 13 (32.5%) 58 (40.0%)  
   Cryptogenic 3 (7.5%) 2 (1.4%)  
Family history of DM*    0.000
   Yes 21 (52.5%) 29 (20.0%)  
   No 19 (47.5%) 116 (80%)  
History of hypertension    0.007
   Yes 10 (25.0%) 13 (9.0%)  
   No 30 (75.0%) 132 (91.0%)  
BMI 27.5 ± 4.6 24.7 ± 4.0 0.009
Interferon therapy    NS
   Yes 6 (15.0%) 49 (33.8%)  
   No 34 (85.0%) 96 (66.2%)  
Smoking    NS
   Yes 13 (32.5%) 37 (25.5%)  
   No 27 (67.5%) 108 (74.5%)  
TG 179.2 ± 74.1 142.8 ± 71.4 NS
Chol 192.4 ± 39.8 174.7 ± 44.4 NS
  1. *Indicates presence of at least one first-degree relative affected by DM.
  2. Includes patients who require diet or antihypertensive agents.